Carregant...

Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes

To prevent hyperinsulinemia, which may cause atherosclerosis, thiazolidinediones (TZDs), also known as insulin sensitizers, are often added to the therapeutic regimen of patients with type 2 diabetes who are receiving insulin. The combination of insulin with pioglitazone, a TZD, reduces glycoated he...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Yamanouchi, Toshikazu
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2856574/
https://ncbi.nlm.nih.gov/pubmed/20407626
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!